Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model

Table 2 Cell growth inhibition of HepG2 cells by 24, 48 and 72 h treatment with 200 μM RES

Cell growth inhibition ratios (%)
Cell groups	time
	24 h	48 h	72 h
HepG2	55.45 ± 1.4	68.91 ± 1.8	78.83 ± 3.9
DMSO	1.00 ± 0.9	1.53 ± 1.6	1.72 ± 0.7
CAV1	68.32 ± 2.0*	80.12 ± 1.7*	90.02 ± 4.0*
CAVM1	55.78 ± 1.0	74.83 ± 2.8	82.46 ± 1.6
CAVM2	57.27 ± 1.2	76.79 ± 1.6	84.35 ± 2.6
CAVRNAi	41.23 ± 1.5*	55.39 ± 1.2*	68.27 ± 1.9*
GFP	54.04 ± 1.6	70.06 ± 1.1	76.27 ± 1.7

ISSN: 1479-5876